Thermo Fisher Scientific Inc., the world leader in serving science, today announced a cooperation agreement with Agere Pharmaceuticals Inc., which will enable customers to accelerate formulation development of pharmaceutical compounds. The partnership is intended to reduce time and cost during proof of concept studies by means of hot melt extrusion and granulation. The two companies also possess a deep know-how in solid dispersions of poorly soluble compounds.Thermo Fisher will install its Thermo Scientific Pharma 16 HME twin-screw extruder at the Agere GMP facility located in Bend, Oregon. Agere can provide in-depth knowledge of solid dispersions and Thermo Fisher offers outstanding experience in hot melt extrusion, which will provide customers the ability to access process or formulation development, scale-up and GMP manufacturing at just one site. Customers will also be able to evaluate formulations using novel testing methodologies and rank formulations with respect to anticipated bioavailability.